The following is a listing of myeloma treatments associated with this tag.
View all treatments in development for myeloma patients around the US.
The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.
The following is a listing of myeloma clinical trials associated with this tag.
View all active clinical trials around the US.
A Feasibility Study Following a Phase 2a Design to Demonstrate Successful Local Manufacture of Chimeric Ant...
LOCAL MANUFACTURE OF CAR-T CELL PRODUCTSA Phase I Study of CD19-Targeted 19(T2)28z1xx Chimeric Antigen Receptor (CAR) Modified T Cells in Adult Pat...
CD19-TARGETED 19(T2)28Z1XX CAR-TImmunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
IMMUNOGLOBULIN REPLACEMENT THERAPYManaged Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to Provide Access for Patients With Out of...
MANAGED ACCESS PROGRAM FOR CTL019TCR-αβ+ and CD19+ Depleted KIR/KIR Ligand-mismatched Haploidentical Hematopoietic Stem Cell Transplant and ...
TCRαβ+/CD19+ DEPLETED HAPLOIDENTICAL HSCTThe following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
The following is a listing of myeloma tags that are associated with this tag.
CAR T Cell
CAR T Cell therapy is a new way to treat multiple myeloma using your own immune system to target and destroy cancer cells.